Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
554 News Items found
Microscope in foreground. GSK Graduate Students in the background.
Training Tomorrow’s Leaders: Graduate Education at GSK

Since its founding 19 years ago, the Gerstner Sloan Kettering Graduate School of Biomedical Sciences has attracted bright minds drawn to its connection to MSK. Learn more about how we're training tomorrow's leaders.
hematopoietic stem and progenitor cells
MSK Researchers Make Strides Against VEXAS Syndrome

VEXAS syndrome is a confounding adult-onset inflammatory disease first described in 2020, which affects 1 in 4,000 men over 50. Now, MSK researchers are shedding new light on its mechanisms and laying the groundwork for potential targeted treatments.
A researcher working in an MSK lab
MSK Research Highlights, September 25, 2025

New MSK research highlights the importance of tumor location in metastasis; shows how regulatory T cells work with sensory nerves in the skin to restrain pain and inflammation; explores whether a large language model can adequately summarize cancer patients’ experiences with pain; and finds proton therapy is effective at treating leptomeningeal metastasis.
Zhi “Zack” Zheng
2025 GSK Chairman’s Prize Recognizes Research on DNA Double-Strand Breaks

This year's GSK Chairman’s Prize was awarded to Zhi “Zack” Zheng for his research on the SPO11 protein, which creates double-strand breaks in DNA.
An MSK researcher points to a scientific image on a screen
MSK Research Highlights, August 8, 2025

New MSK research develops a powerful new resource for studying gene regulation across eukaryotes; uncovers how “jumping genes” can drive cancer growth; describes how an unexpected oxygen sensor regulates ferroptosis; establishes a technique to map chromatin architecture in 3D; creates new models for studying schizophrenia-associated defects; and finds transcription factor 19 is critical for the responses of natural killer cells to viral infection.
Joan Massagué
How Cancer Spreads: Four Emerging Insights About Metastasis

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.
Justin Perry
High-Fructose Diet Harms Neurodevelopment and Leads to Anxiety in Mice, MSK Study Finds

A new laboratory study from MSK is shedding light on the mechanisms by which high fructose consumption early in life may directly impact brain development and increase the risk of anxiety disorders later on.
Bacillus Calmette-Guerin (BCG) vaccine
New Understanding of a Decades-Old Bladder Cancer Treatment Could Help Improve Immunotherapies More Broadly

A team of researchers from MSK and Weill Cornell Medicine is expanding the understanding of how a decades-old treatment for bladder cancer works — an understanding that could help improve the effectiveness of immunotherapies more broadly.
A researcher working in an MSK lab
MSK Research Highlights, May 19, 2025

New MSK research uncovers new details of the immune response against leptomeningeal metastasis; develops a grading system to assess the risk of developing thrombocytopenia after CAR T cell therapy; and outlines a method for scientists to estimate metabolic characteristics from challenging clinical samples.
A lab coat with an MSK logo hangs on a hook
Meet the 2025 Graduates of the Gerstner Sloan Kettering Graduate School

Fourteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 14, 2025, as part of Memorial Sloan Kettering’s 46th annual academic convocation.